Net Loss of Transgene Biotek reported to Rs 0.09 crore in the quarter ended December 2024 as against net loss of Rs 0.12 crore during the previous quarter ended December 2023. Sales rose 60.00% to Rs 0.08 crore in the quarter ended December 2024 as against Rs 0.05 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales0.080.05 60 OPM %-112.50-200.00 - PBDT-0.07-0.10 30 PBT-0.09-0.12 25 NP-0.09-0.12 25 Powered by Capital Market - Live News

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 24 January 2025.Powered by Capital Market - Live News

Net Loss of Transgene Biotek reported to Rs 0.07 crore in the quarter ended September 2024 as against net loss of Rs 0.13 crore during the previous quarter ended September 2023. Sales rose 20.00% to Rs 0.06 crore in the quarter ended September 2024 as against Rs 0.05 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.060.05 20 OPM %-116.67-240.00 - PBDT-0.05-0.11 55 PBT-0.07-0.13 46 NP-0.07-0.13 46 Powered by Capital Market - Live News

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live News

Net profit of Transgene Biotek reported to Rs 0.20 crore in the quarter ended June 2024 as against net loss of Rs 0.13 crore during the previous quarter ended June 2023. Sales declined 50.00% to Rs 0.05 crore in the quarter ended June 2024 as against Rs 0.10 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.050.10 -50 OPM %-820.00-120.00 - PBDT0.22-0.11 LP PBT0.20-0.13 LP NP0.20-0.13 LP Powered by Capital Market - Live News